Erratum: Glutathione Primes T Cell Metabolism for Inflammation (Immunityn (2017) 46(4) (675–689) (S1074761317301292) (10.1016/j.immuni.2017.03.019));Glutathione Primes T Cell Metabolism for Inflammation

Immunity

Volumn 46, Issue 4, 2017, Pages 675-689

  Mak, Tak W ^a,b   Grusdat, Melanie ^c   Duncan, Gordon S ^a   Dostert, Catherine ^c   Nonnenmacher, Yannic ^d,e   Cox, Maureen ^a   Binsfeld, Carole ^c   Hao, Zhenyue ^a,f   Brüstle, Anne ^g   Itsumi, Momoe ^h   Jäger, Christian ^e   Chen, Ying ⁱ   Pinkenburg, Olaf ^j   Camara, Bärbel ^j   Ollert, Markus ^c,k   Bindslev Jensen, Carsten ^k   Vasiliou, Vasilis ⁱ   Gorrini, Chiara ^a   Lang, Philipp A ^l   Lohoff, Michael ^j   Harris, Isaac S ^m   Hiller, Karsten ^d,e,n   Brenner, Dirk ^c,k   more..

^a The Campbell Family Cancer Research Institute and University Health Network   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^d TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^e UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^f UNIVERSITY OF TORONTO   (Canada)

^g Biology and Environment   (Australia)

^h TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

ⁱ YALE UNIVERSITY   (United States)

^j PHILIPPS UNIVERSITY MARBURG   (Germany)

^k ODENSE UNIVERSITY HOSPITAL   (Denmark)

^l HEINRICH HEINE UNIVERSITY   (Germany)

^m HARVARD MEDICAL SCHOOL   (United States)

ⁿ HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

more..

Author keywords

Gclc; glutathione; glycolysis; GSH; metabolic reprogramming; metabolism; mTOR; Myc; NFAT; reactive oxygen species; ROS; T cells

Indexed keywords

CALCINEURIN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; INTERLEUKIN 17; INTERLEUKIN 2; LACTATE DEHYDROGENASE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYC PROTEIN; PYRUVATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; STAPHYLOCOCCUS ENTEROTOXIN B; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NFAT; GLUTAMINE; MTOR PROTEIN, MOUSE; MYC PROTEIN, MOUSE; TARGET OF RAPAMYCIN KINASE;

AEROBIC GLYCOLYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON SOURCE; CELL DAMAGE; CELL DEATH; CELL GROWTH; CELL METABOLISM; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVE SITE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FLOW CYTOMETRY; GENE TARGETING; GLUCOSE INTAKE; GLUCOSE METABOLISM; HOMEOSTASIS; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYNTHESIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; DEFICIENCY; GENETICS; GLYCOLYSIS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENERGY METABOLISM; GLUTAMATE-CYSTEINE LIGASE; GLUTAMINE; GLUTATHIONE; GLYCOLYSIS; IMMUNOBLOTTING; INFLAMMATION; MICE, INBRED C57BL; MICE, KNOCKOUT; NFATC TRANSCRIPTION FACTORS; PROTO-ONCOGENE PROTEINS C-MYC; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOR SERINE-THREONINE KINASES;

EID: 85019044532     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2017.06.009     Document Type: Erratum

References (55)

1. Ahmed, R., Salmi, A., Butler, L.D., Chiller, J.M., Oldstone, M.B., Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160 (1984), 521–540.
2. Babcock, J.T., Nguyen, H.B., He, Y., Hendricks, J.W., Wek, R.C., Quilliam, L.A., Mammalian target of rapamycin complex 1 (mTORC1) enhances bortezomib-induced death in tuberous sclerosis complex (TSC)-null cells by a c-MYC-dependent induction of the unfolded protein response. J. Biol. Chem. 288 (2013), 15687–15698.
3. Battello, N., Zimmer, A.D., Goebel, C., Dong, X., Behrmann, I., Haan, C., Hiller, K., Wegner, A., The role of HIF-1 in oncostatin M-dependent metabolic reprogramming of hepatic cells. Cancer Metab., 4, 2016, 3.
4. Brenner, D., Brüstle, A., Lin, G.H., Lang, P.A., Duncan, G.S., Knobbe-Thomsen, C.B., St Paul, M., Reardon, C., Tusche, M.W., Snow, B., et al. Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells. Proc. Natl. Acad. Sci. USA 111 (2014), 1060–1065.
5. Brownlie, R.J., Zamoyska, R., T cell receptor signalling networks: branched, diversified and bounded. Nat. Rev. Immunol. 13 (2013), 257–269.
6. Brüstle, A., Heink, S., Huber, M., Rosenplänter, C., Stadelmann, C., Yu, P., Arpaia, E., Mak, T.W., Kamradt, T., Lohoff, M., The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8 (2007), 958–966.
7. Brüstle, A., Brenner, D., Knobbe, C.B., Lang, P.A., Virtanen, C., Hershenfield, B.M., Reardon, C., Lacher, S.M., Ruland, J., Ohashi, P.S., Mak, T.W., The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells. J. Clin. Invest. 122 (2012), 4698–4709.
8. Buchholz, M., Schatz, A., Wagner, M., Michl, P., Linhart, T., Adler, G., Gress, T.M., Ellenrieder, V., Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway. EMBO J. 25 (2006), 3714–3724.
9. Cairns, R.A., Harris, I.S., Mak, T.W., Regulation of cancer cell metabolism. Nat. Rev. Cancer 11 (2011), 85–95.
10. Carr, E.L., Kelman, A., Wu, G.S., Gopaul, R., Senkevitch, E., Aghvanyan, A., Turay, A.M., Frauwirth, K.A., Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J. Immunol. 185 (2010), 1037–1044.
11. Chang, C.H., Curtis, J.D., Maggi, L.B. Jr., Faubert, B., Villarino, A.V., O'Sullivan, D., Huang, S.C., van der Windt, G.J., Blagih, J., Qiu, J., et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153 (2013), 1239–1251.
12. Chen, Y., Shertzer, H.G., Schneider, S.N., Nebert, D.W., Dalton, T.P., Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels. J. Biol. Chem. 280 (2005), 33766–33774.
13. Chen, Y., Yang, Y., Miller, M.L., Shen, D., Shertzer, H.G., Stringer, K.F., Wang, B., Schneider, S.N., Nebert, D.W., Dalton, T.P., Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure. Hepatology 45 (2007), 1118–1128.
14. David, C.J., Chen, M., Assanah, M., Canoll, P., Manley, J.L., HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463 (2010), 364–368.
15. Devadas, S., Zaritskaya, L., Rhee, S.G., Oberley, L., Williams, M.S., Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J. Exp. Med. 195 (2002), 59–70.
16. Douglas, N.C., Jacobs, H., Bothwell, A.L., Hayday, A.C., Defining the specific physiological requirements for c-Myc in T cell development. Nat. Immunol. 2 (2001), 307–315.
17. Düvel, K., Yecies, J.L., Menon, S., Raman, P., Lipovsky, A.I., Souza, A.L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39 (2010), 171–183.
18. Frauwirth, K.A., Riley, J.L., Harris, M.H., Parry, R.V., Rathmell, J.C., Plas, D.R., Elstrom, R.L., June, C.H., Thompson, C.B., The CD28 signaling pathway regulates glucose metabolism. Immunity 16 (2002), 769–777.
19. Gerriets, V.A., Rathmell, J.C., Metabolic pathways in T cell fate and function. Trends Immunol. 33 (2012), 168–173.
20. Gorrini, C., Harris, I.S., Mak, T.W., Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 12 (2013), 931–947.
21. Gülow, K., Kaminski, M., Darvas, K., Süss, D., Li-Weber, M., Krammer, P.H., HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death. J. Immunol. 174 (2005), 5249–5260.
22. Hahn-Windgassen, A., Nogueira, V., Chen, C.C., Skeen, J.E., Sonenberg, N., Hay, N., Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J. Biol. Chem. 280 (2005), 32081–32089.
23. Hardie, D.G., Ross, F.A., Hawley, S.A., AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13 (2012), 251–262.
24. Harris, I.S., Treloar, A.E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K.C., Yung, K.Y., Brenner, D., Knobbe-Thomsen, C.B., Cox, M.A., et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27 (2015), 211–222.
25. Hörig, H., Spagnoli, G.C., Filgueira, L., Babst, R., Gallati, H., Harder, F., Juretic, A., Heberer, M., Exogenous glutamine requirement is confined to late events of T cell activation. J. Cell. Biochem. 53 (1993), 343–351.
26. Hosoi, H., Dilling, M.B., Liu, L.N., Danks, M.K., Shikata, T., Sekulic, A., Abraham, R.T., Lawrence, J.C. Jr., Houghton, P.J., Studies on the mechanism of resistance to rapamycin in human cancer cells. Mol. Pharmacol. 54 (1998), 815–824.
27. Hwang, N.R., Yim, S.H., Kim, Y.M., Jeong, J., Song, E.J., Lee, Y., Lee, J.H., Choi, S., Lee, K.J., Oxidative modifications of glyceraldehyde-3-phosphate dehydrogenase play a key role in its multiple cellular functions. Biochem. J. 423 (2009), 253–264.
28. Inoki, K., Li, Y., Zhu, T., Wu, J., Guan, K.L., TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4 (2002), 648–657.
29. Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126 (2006), 955–968.
30. Jackson, S.H., Devadas, S., Kwon, J., Pinto, L.A., Williams, M.S., T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat. Immunol. 5 (2004), 818–827.
31. Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H., Karin, M., Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005), 649–661.
32. Köenig, A., Linhart, T., Schlengemann, K., Reutlinger, K., Wegele, J., Adler, G., Singh, G., Hofmann, L., Kunsch, S., Büch, T., et al. NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells. Gastroenterology, 138, 2010 1189–99.e1, 2.
33. Langrish, C.L., Chen, Y., Blumenschein, W.M., Mattson, J., Basham, B., Sedgwick, J.D., McClanahan, T., Kastelein, R.A., Cua, D.J., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 (2005), 233–240.
34. Laplante, M., Sabatini, D.M., mTOR signaling in growth control and disease. Cell 149 (2012), 274–293.
35. Matsushita, M., Freigang, S., Schneider, C., Conrad, M., Bornkamm, G.W., Kopf, M., T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J. Exp. Med. 212 (2015), 555–568.
36. McCubrey, J.A., Lahair, M.M., Franklin, R.A., Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid. Redox Signal. 8 (2006), 1775–1789.
37. Meister, A., Selective modification of glutathione metabolism. Science 220 (1983), 472–477.
38. Nakaya, M., Xiao, Y., Zhou, X., Chang, J.H., Chang, M., Cheng, X., Blonska, M., Lin, X., Sun, S.C., Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity 40 (2014), 692–705.
39. Namgaladze, D., Hofer, H.W., Ullrich, V., Redox control of calcineurin by targeting the binuclear Fe(2+)-Zn(2+) center at the enzyme active site. J. Biol. Chem. 277 (2002), 5962–5969.
40. Newsholme, E.A., Crabtree, B., Ardawi, M.S., Glutamine metabolism in lymphocytes: Its biochemical, physiological and clinical importance. Q. J. Exp. Physiol. 70 (1985), 473–489.
41. Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136 (2009), 521–534.
42. Pearce, E.L., Pearce, E.J., Metabolic pathways in immune cell activation and quiescence. Immunity 38 (2013), 633–643.
43. Pollizzi, K.N., Powell, J.D., Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat. Rev. Immunol. 14 (2014), 435–446.
44. Rusnak, F., Mertz, P., Calcineurin: form and function. Physiol. Rev. 80 (2000), 1483–1521.
45. Schmidt, E.V., Ravitz, M.J., Chen, L., Lynch, M., Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway. Cell Cycle 8 (2009), 1344–1351.
46. Sena, L.A., Chandel, N.S., Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48 (2012), 158–167.
47. Sena, L.A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D.A., Wang, C.R., Schumacker, P.T., Licht, J.D., Perlman, H., et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38 (2013), 225–236.
48. Sinclair, L.V., Rolf, J., Emslie, E., Shi, Y.B., Taylor, P.M., Cantrell, D.A., Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14 (2013), 500–508.
49. Singh, G., Singh, S.K., König, A., Reutlinger, K., Nye, M.D., Adhikary, T., Eilers, M., Gress, T.M., Fernandez-Zapico, M.E., Ellenrieder, V., Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-beta switch from a suppressor to a promoter of cancer cell proliferation. J. Biol. Chem. 285 (2010), 27241–27250.
50. Verbist, K.C., Guy, C.S., Milasta, S., Liedmann, S., Kamiński, M.M., Wang, R., Green, D.R., Metabolic maintenance of cell asymmetry following division in activated T lymphocytes. Nature 532 (2016), 389–393.
51. Wang, R., Dillon, C.P., Shi, L.Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L.L., Fitzgerald, P., Chi, H., Munger, J., Green, D.R., The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35 (2011), 871–882.
52. West, M.J., Stoneley, M., Willis, A.E., Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway. Oncogene 17 (1998), 769–780.
53. Wolfer, A., Bakker, T., Wilson, A., Nicolas, M., Ioannidis, V., Littman, D.R., Lee, P.P., Wilson, C.B., Held, W., MacDonald, H.R., Radtke, F., Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat. Immunol. 2 (2001), 235–241.
54. Yaqoob, P., Calder, P.C., Glutamine requirement of proliferating T lymphocytes. Nutrition 13 (1997), 646–651.
55. Yi, J.S., Holbrook, B.C., Michalek, R.D., Laniewski, N.G., Grayson, J.M., Electron transport complex I is required for CD8+ T cell function. J. Immunol. 177 (2006), 852–862.